Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 15th – 21st, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
10. Michigan’s Cannabis Industry is Thriving and This Company is Dominating the State with a 22% Share of the Market
Weekly Recreational Cannabis Sales in Michigan Recently Surpass Medical Sales for the First Time Since the State’s Adult Use Market Opened in December 2019
The newly public ‘Super State Operator’ Red White & Bloom (OTCQX:TDRYD) has been quietly cornering the highly lucrative Michigan cannabis market and thanks to its first-mover advantage, RWB now controls a 22% market share in the Great Lakes State.
READ FULL RWB ARTICLE
9. MindMed to Commence Phase 1 Clinical Trials on DMT, the Active Psychedelic Ingredient in Ayahuasca
The Phase 1 Clinical Trials Will Put MindMed in a Position to Potentially Progress to Future Phase 2A Proof of Concept Trials Down the Road
MindMed (OTCQB:MMEDF) plans to use the Phase 1 Study to experiment with dosing methods to better understand how humans react to Ayahuasca’s active Psychedelic ingredient, DMT.
READ FULL MINDMED ARTICLE
8. Charlotte’s Web Snares Abacus, CEO Looks Forward To ‘$10B Market Opportunity’
When Charlotte’s Web Agreed to Buy Abacus Health in March, Expectations Were High
The deal between Charlotte’s Web (OTCQX:CWBHF) and Abacus Health Products (OTCQX:ABAHF), valued at CA$99 million ($68.2 million), would form one of the biggest vertically integrated hemp-derived CBD companies and give Charlotte’s Web about 35% of U.S. CBD sales.
READ FULL CHARLOTTE’S WEB ARTICLE
7. Marijuana Firm Acreage Holdings Gets $15 Million Loan at 60% Interest Rate
The Secured Note, Obtained From an Unidentified Institutional Investor, Matures in Four Months, According to a News Release
Marijuana multistate operator Acreage Holdings (OTCQX:ACRGF) has secured a $15 million short-term loan with a whopping 60% yearly interest rate, the company said Wednesday.
READ FULL ACREAGE HOLDINGS ARTICLE
6. Psychedelics Quickly Creating a Potential $100 Billion Market Opportunity
Psychedelics May Soon Disrupt Traditional Medicine and Create a $100 Billion Market Opportunity
In fact, according to analysts at Eight Capital, “The addressable market is incredibly large, and we’re still in the early innings of what any sort of psychedelic treatment could do to resolve some of these important issues.”
READ FULL PSYCHEDELICS MARKET ARTICLE
5. 3 Cannabis Stocks with the Highest Dividend Yields
Here’s Which One Looks Like the Best Pick Right Now
When you think of Cannabis Stocks, the idea of receiving dividends probably doesn’t come to mind. However, there are a handful of companies with close ties to the cannabis industry that do offer dividends. Here are three Marijuana Stocks with the highest dividend yields of all.
READ FULL CANNABIS DIVIDENDS ARTICLE
4. Investing in Psychedelic Mushroom Stocks
There is Now a Publicly-Traded Psychedelics Company That Has a License to Conduct the Kind of Research That Would’ve Been Unheard of Just Five Years Ago
Last week, Numinus Wellness (OTC:LKYSD), a company that provides testing for Psychedelic therapies that address mental illness and addiction, announced that Health Canada approved to amend the company’s license to allow Numinus to conduct research to standardize the extraction of Psilocybin from mushrooms.
READ FULL PSYCHEDELIC STOCKS ARTICLE
3. American Cannabis Could See Increased Attention on U.S. Markets
New Cannabis Ventures Alan Brochstein Shares His Views on How He’s Seeing Increased Interest From U.S. Stock Exchanges Potentially Listing U.S. Cannabis Companies
In addition, Brochstein also explores how COVID-19 could inspire Cannabis companies to work together to find more profit through unification on the legal market versus the illegal market. In a time where health and wellness supersede everything, quality assurance and safety measures are presenting a big opportunity for the legal market to thrive.
READ FULL U.S. CANNABIS ARTICLE
2. Champignon’s CEO and CRTCE Founder Dr. Mcintyre Published in Two Peer-Reviewed Study Journals
CRTCE’s Leading Academic Footprint Facility Showing Significant Outcomes in the Arena of Psychedelic Medicine
Champignon Brands (OTCQB:SHRMF) continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (MDD) while demonstrating rapid onset efficacy and safety of its treatment processes. The company announced that its CEO, Dr. Roger McIntyre, and the Canadian Rapid Treatment Centre of Excellence (CRTCE) has been recently published in two peer-reviewed study journals focusing on ketamine’s safety, tolerability and effectiveness.
READ FULL CHAMPIGNON BRANDS ARTICLE
1. VIDEO: TCI Interviews Brad Rogers, CEO of Super State Operator Red White & Bloom
TCI Host Alyssa Boston (Miss Universe Canada 2019 + Cannabis Crusader) Recently Sat Down with Brad Rogers, CEO of Red White & Bloom
Brad Rogers, CEO of ‘Super State Operator’ Red White & Bloom (OTC:TDRYD) shares his thoughts on the U.S. cannabis industry as well as his vision for RWB following the company’s successful IPO.
WATCH FULL RED WHITE & BLOOM VIDEO
Photo by Roberto Valdivia on Unsplash
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights